• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一级亲属中原发性硬化性胆管炎的患病率增加。

Increased prevalence of primary sclerosing cholangitis among first-degree relatives.

作者信息

Bergquist Annika, Lindberg Greger, Saarinen Susanne, Broomé Ulrika

机构信息

Department of Gastroenterology and Hepatology, Karolinska University Hospital, Huddinge, Karolinska Institutet, Stockholm, 141 86 Huddinge, Sweden.

出版信息

J Hepatol. 2005 Feb;42(2):252-6. doi: 10.1016/j.jhep.2004.10.011.

DOI:10.1016/j.jhep.2004.10.011
PMID:15664252
Abstract

BACKGROUND/AIMS: The aim of the present study was to investigate the familial occurrence of autoimmune diseases in a large group of patients with primary sclerosing cholangitis (PSC).

METHODS

All patients with PSC treated at Huddinge University Hospital between 1984 and 1999 were included (n=145). For every patient with PSC and inflammatory bowel disease (IBD) (n=126) we randomly selected a control patient with IBD (n=126), matched for age, sex and type of IBD. A questionnaire comprising information about autoimmune diseases among first-degree relatives was answered by all patients and controls.

RESULTS

We identified 22 index cases with PSC from 21 families with a first-degree relative with either chronic liver disease and/or IBD. Five patients with PSC had a first-degree relative with PSC (3.4%). The prevalence of PSC among first-degree relatives was 0.7% (5/717). In siblings the prevalence was 1.5% (4/269). The prevalence of first-degree relatives with autoimmune diseases outside the liver was similar in PSC patients and controls.

CONCLUSIONS

First-degree relatives of patients with PSC have a PSC prevalence of 0.7%. This represents a nearly 100-fold increased risk of developing PSC compared with the general population, supporting the hypothesis that genetic factors are of importance for development of PSC.

摘要

背景/目的:本研究旨在调查一大群原发性硬化性胆管炎(PSC)患者自身免疫性疾病的家族发生率。

方法

纳入1984年至1999年间在胡丁厄大学医院接受治疗的所有PSC患者(n = 145)。对于每一位患有PSC和炎症性肠病(IBD)的患者(n = 126),我们随机选择一名患有IBD的对照患者(n = 126),根据年龄、性别和IBD类型进行匹配。所有患者和对照者都回答了一份包含一级亲属自身免疫性疾病信息的问卷。

结果

我们从21个有一级亲属患有慢性肝病和/或IBD的家庭中确定了22例PSC索引病例。5例PSC患者有一级亲属患有PSC(3.4%)。一级亲属中PSC的患病率为0.7%(5/717)。在兄弟姐妹中患病率为1.5%(4/269)。PSC患者和对照者中肝脏外自身免疫性疾病一级亲属的患病率相似。

结论

PSC患者的一级亲属中PSC患病率为0.7%。与普通人群相比,这代表着患PSC的风险增加了近100倍,支持了遗传因素对PSC发病具有重要意义的假说。

相似文献

1
Increased prevalence of primary sclerosing cholangitis among first-degree relatives.一级亲属中原发性硬化性胆管炎的患病率增加。
J Hepatol. 2005 Feb;42(2):252-6. doi: 10.1016/j.jhep.2004.10.011.
2
Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者一级亲属中患原发性硬化性胆管炎和溃疡性结肠炎的风险增加。
Clin Gastroenterol Hepatol. 2008 Aug;6(8):939-43. doi: 10.1016/j.cgh.2008.03.016.
3
Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者自身免疫性疾病的发病率增加。
Am J Gastroenterol. 2000 Nov;95(11):3195-9. doi: 10.1111/j.1572-0241.2000.03292.x.
4
Fatigue in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者的疲劳
Scand J Gastroenterol. 2004 Oct;39(10):961-8. doi: 10.1080/00365520410003434.
5
What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?在土耳其患者中,原发性硬化性胆管炎与性别及炎症性肠病之间有何关联?
Hepatogastroenterology. 1998 Nov-Dec;45(24):2064-72.
6
Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.原发性硬化性胆管炎及其他自身免疫性疾病患者中谷胱甘肽S-转移酶θ1自身抗体的研究
J Autoimmun. 2008 Jun;30(4):273-82. doi: 10.1016/j.jaut.2007.11.008. Epub 2008 Feb 1.
7
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.与炎症性肠病相关的基因多态性不会增加原发性硬化性胆管炎的发病风险。
Am J Gastroenterol. 2007 Jan;102(1):115-21. doi: 10.1111/j.1572-0241.2006.00928.x. Epub 2006 Nov 13.
8
Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.原发性硬化性胆管炎患者行回肠储袋肛管吻合术的手术结果:一项病例对照研究。
Surgery. 2005 Oct;138(4):631-7; discussion 637-9. doi: 10.1016/j.surg.2005.07.014.
9
Primary sclerosing cholangitis can present with acute liver failure: Report of two cases.原发性硬化性胆管炎可表现为急性肝衰竭:两例报告。
J Hepatol. 2006 May;44(5):1005-8. doi: 10.1016/j.jhep.2006.01.033. Epub 2006 Feb 28.
10
Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者的囊性纤维化跨膜传导调节因子基因多态性
J Hepatol. 2009 Jan;50(1):150-7. doi: 10.1016/j.jhep.2008.07.033. Epub 2008 Oct 7.

引用本文的文献

1
HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives.易患自身免疫性疾病的人类白细胞抗原(HLA)等位基因与青少年自身免疫性肝病患者及其一级亲属的免疫调节受损有关。
J Autoimmun. 2025 Jun;154:103436. doi: 10.1016/j.jaut.2025.103436. Epub 2025 May 6.
2
Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.儿童免疫介导性胆管病:为寻找未来可能的治疗靶点,需要更好地了解其病理生理学。
Front Immunol. 2023 Oct 20;14:1206025. doi: 10.3389/fimmu.2023.1206025. eCollection 2023.
3
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review.
原发性硬化性胆管炎与炎症性肠病:综述
J Clin Transl Hepatol. 2022 Jun 28;10(3):531-542. doi: 10.14218/JCTH.2021.00344. Epub 2022 Jan 20.
4
Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns.环境暴露作为肝脏疾病的风险调节因素:已知与未知
Acta Pharm Sin B. 2021 Dec;11(12):3768-3778. doi: 10.1016/j.apsb.2021.09.005. Epub 2021 Sep 10.
5
Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis.原发性胆汁性胆管炎和原发性硬化性胆管炎的地理流行病学及环境协变量绘图
JHEP Rep. 2020 Nov 4;3(1):100202. doi: 10.1016/j.jhepr.2020.100202. eCollection 2021 Feb.
6
Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review.原发性硬化性胆管炎与原发性胆汁性肝硬化重叠综合征:综述
J Clin Transl Hepatol. 2020 Sep 28;8(3):336-346. doi: 10.14218/JCTH.2020.00036. Epub 2020 Aug 24.
7
Clinical guidelines for primary sclerosing cholangitis 2017.2017 年原发性硬化性胆管炎临床指南。
J Gastroenterol. 2018 Sep;53(9):1006-1034. doi: 10.1007/s00535-018-1484-9. Epub 2018 Jun 27.
8
Pathogenesis and clinical spectrum of primary sclerosing cholangitis.原发性硬化性胆管炎的发病机制与临床谱
World J Gastroenterol. 2017 Apr 14;23(14):2459-2469. doi: 10.3748/wjg.v23.i14.2459.
9
The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood.遗传和免疫因素在儿童原发性硬化性胆管炎发病机制中的作用
Gastroenterol Res Pract. 2016;2016:3905240. doi: 10.1155/2016/3905240. Epub 2016 Nov 2.
10
The Immunogenetics of Autoimmune Cholestasis.自身免疫性胆汁淤积的免疫遗传学
Clin Liver Dis. 2016 Feb;20(1):15-31. doi: 10.1016/j.cld.2015.08.002.